Poly(ε-caprolactone) and poly (L-lactic-co-glycolic acid) degradable polymer sponges attenuate astrocyte response and lesion growth in acute traumatic brain injury

Tissue Engineering

Volumn 13, Issue 10, 2007, Pages 2515-2523

  Wong, Darice Y ^a,b   Hollister, Scott J ^a,b   Krebsbach, Paul H ^a   Nosrat, Christopher ^a,c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTES; ASTROCYTIC ACTIVATION; CEREBRAL CORTEX; LESION GROWTH;

BIOCOMPATIBILITY; BIODEGRADABILITY; BRAIN; ORGANIC ACIDS; PH EFFECTS; RATS; TISSUE ENGINEERING;

BIOPOLYMERS;

BETA TUBULIN; BETA TUBULIN TYPE III; BIOMATERIAL; EOSIN; GELATIN SPONGE; GLIAL FIBRILLARY ACIDIC PROTEIN; HEMATOXYLIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MICROSPHERE; NESTIN; POLYCAPROLACTONE; POLYGLACTIN; UNCLASSIFIED DRUG; AQUAPLAST, CAPROLACTONE; LACTIC ACID; POLYESTER; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; POLYMER;

ACIDITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BIOCOMPATIBILITY; BRAIN CORTEX; BRAIN DAMAGE; CELL INFILTRATION; CONTROLLED STUDY; DEATH; DEGRADATION; FEMALE; IMMUNOFLUORESCENCE; IMPLANT; INFLAMMATION; MACROPHAGE ACTIVATION; MICROGLIA; MORPHOLOGY; NERVE CELL GROWTH; NONHUMAN; POROSITY; PRIORITY JOURNAL; RAT; SCAR FORMATION; STAINING; STEM CELL; TISSUE ENGINEERING; TRAUMATIC BRAIN INJURY; ANIMAL; BIODEGRADABLE IMPLANT; BRAIN INJURY; DRUG EFFECT; PATHOLOGY; SPRAGUE DAWLEY RAT; TREATMENT OUTCOME;

RATTUS;

ABSORBABLE IMPLANTS; ANIMALS; ASTROCYTES; BIOCOMPATIBLE MATERIALS; BRAIN INJURIES; FEMALE; LACTIC ACID; POLYESTERS; POLYGLYCOLIC ACID; POLYMERS; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 35348874751     PISSN: 10763279     EISSN: None     Source Type: Journal    
DOI: 10.1089/ten.2006.0440     Document Type: Article

References (35)

1. Johann, V., Schiefer, J., Sass, C., Mey, J., Brook, G., Kruttgen, A., Schlangen, C., Bernreuther, C., Schachner, M., Dihne, M., and Kosinski, C.M. Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease. Exp Brain Res 177, 458, 2007.
2. Thompson, T.P., Lunsford, L.D., and Kondziolka, D. Restorative neurosurgery: Opportunities for restoration of function in acquired, degenerative, and idiopathic neurological diseases. Neurosurgery 45, 741, 1999.
3. Park, K.I., Teng, Y.D., and Snyder, E.Y. The injured brain interacts reciprocally with neural stem cells supported by scaffolds to reconstitute lost tissue. Nat Biotechnol 20, 1111, 2002.
4. Tate, M.C., Shear, D.A., Hoffman, S.W., Stein, D.G., and LaPlaca, M.C. Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials 22, 1113, 2001.
5. Tian, W.M., Hou, S.P., Ma, J., Zhang, C.L., Xu, Q.Y., Lee, I.S., Li, H.D., Spector, M., and Cui, F.Z. Hyaluronic acidpoly-D-lysine-based three-dimensional hydrogel for traumatic brain injury. Tissue Eng 11, 513, 2005.
6. Popovic, N., and Brundin, P. Therapeutic potential of controlled drug delivery systems in neurodegenerative diseases. Int J Pharm 314, 120, 2006.
7. Kou, J.H., Emmett, C., Shen, P., Aswani, S., Iwamoto, T., Vaghefi, F., Cain, G., and Sanders, L. Bioerosion and biocompatibility of poly(d,l-lactic-co-glycolic acid) implants in brain. J Control Release 43, 123, 1997.
8. Fournier, E., Passirani, C., Montero-Menei, C.N., and Benoit, J.P. Biocompatibility of implantable synthetic polymeric drug carriers: focus on brain biocompatibility. Biomaterials 24, 3311, 2003.
9. Menei, P., Croue, A., Daniel, V., Pouplardbarthelaix, A., and Benoit, J.P. Fate and biocompatibility of 3 types of microspheres implanted into the brain. J Biomed Mater Res 28, 1079, 1994.
10. Tang, Z.G., Black, R.A., Curran, J.M., Hunt, J.A., Rhodes, N.P., and Williams, D.F. Surface properties and biocompatibility of solvent-cast poly[epsilon-caprolactone] films. Biomaterials 25, 4741, 2004.
11. Taylor, M.S., Daniels, A.U., Andriano, K.P., and Heller, J. 6 Bioabsorbable Polymers - in-Vitro Acute Toxicity of Accumulated Degradation Products. J Appl Biomater 5, 151, 1994.
12. Sun, H.F., Mei, L., Song, C.X., Cui, X.M., and Wang, P.Y. The in vivo degradation, absorption and excretion of PCL-based implant. Biomaterials 27, 1735, 2006.
13. Polikov, V.S., Tresco, P.A., and Reichert, W.M. Response of brain tissue to chronically implanted neural electrodes. J Neurosci Meth 148, 1, 2005.
14. Williams, A.J., Hartings, J.A., Lu, X.C., Rolli, M.L., and Tortella, F.C. Penetrating ballistic-like brain injury in the rat: differential time courses of hemorrhage, cell death, inflammation, and remote degeneration. J Neurotrauma 23, 1828, 2006.
15. Bramlett, H.M., and Dietrich, W.D. Pathophysiology of cerebral ischemia and brain trauma: similarities and differences. J Cereb Blood Flow Metab 24, 133, 2004.
16. Sung, H.J., Meredith, C., Johnson, C., and Galis, Z.S. The effect of scaffold degradation rate on three-dimensional cell growth and angiogenesis. Biomaterials 25, 5735, 2004.
17. Chen, S., Pickard, J.D., and Harris, N.G. Time course of cellular pathology after controlled cortical impact injury. Exp Neurol 182, 87, 2003.
18. Whiteland, J.L., Nicholls, S.M., Shimeld, C., Easty, D.L., Williams, N.A., and Hill, T.J. Immunohistochemical detection of T-cell subsets and other leukocytes in paraffinembedded rat and mouse tissues with monoclonal antibodies. J Histochem Cytochem 43, 313, 1995.
19. McMaster, W.R., and Williams, A.F. Identification of Ia glycoproteins in rat thymus and purification from rat spleen. Eur J Immunol 9, 426, 1979.
20. Hockfield, S., and McKay, R.D. Identification of major cell classes in the developing mammalian nervous system. J Neurosci 5, 3310, 1985.
21. Hartfuss, E., Galli, R., Heins, N., and Gotz, M. Characterization of CNS precursor subtypes and radial glia. Develop Biol 229, 15, 2001.
22. Mozzetti, S., Ferlini, C., Concolino, P., Filippetti, F., Raspaglio, G., Prislei, S., Gallo, D., Martinelli, E., Ranelletti, F.O., Ferrandina, G., and Scambia, G. Class III beta-tubulin overexpression is a prominent mechanism of paclitaxel resistance in ovarian cancer patients. Clin Cancer Res 11, 298, 2005.
23. Zhang, Y.W., Denham, J., and Thies, R.S. Oligodendrocyte progenitor cells derived from human embryonic stem cells express neurotrophic factors. Stem Cells Devel 15, 943, 2006.
24. Saadoun, S., Papadopoulos, M.C., Davies, D.C., Krishna, S., and Bell, B.A. Aquaporin-4 expression is increased in oedematous human brain tumours. J Neurol Neurosurg Psychiatry 72, 262, 2002.
25. Dehay, C., Savatier, P., Cortay, V., and Kennedy, H. Cell-cycle kinetics of neocortical precursors are influenced by embryonic thalamic axons. J Neurosci 21, 201, 2001.
26. Jones, N.M., and Bergeron, M. Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J Neurochem 89, 157, 2004.
27. Stidworthy, M.F., Genoud, S., Li, W.W., Leone, D.P., Mantei, N., Suter, U., and Franklin, R.J. Notch1 and Jagged1 are expressed after CNS demyelination, but are not a major rate-determining factor during remyelination. Brain 127, 1928, 2004.
28. Aihara, N., Hall, J.J., Pitts, L.H., Fukuda, K., and Noble, L.J. Altered immunoexpression of microglia and macrophages after mild head injury. J Neurotrauma 12, 53, 1995.
29. Holmin, S., and Mathiesen, T. Biphasic edema development after experimental brain contusion in rat. Neurosci Lett 194, 97, 1995.
30. Bianco, F., Pravettoni, E., Colombo, A., Schenk, U., Moller, T., Matteoli, M., and Verderio, C. Astrocyte-derived ATP induces vesicle shedding and IL-1 beta release from microglia. J Immunol 174, 7268, 2005.
31. Luo, J., Borgens, R., and Shi, R. Polyethylene glycol improves function and reduces oxidative stress in synaptosomal preparations following spinal cord injury. J Neurotrauma 21, 994, 2004.
32. Kerwin, B.A., Chang, B.S., Gegg, C.V., Gonnelli, M., Li, T., and Strambini, G.B. Interactions between PEG and type I soluble tumor necrosis factor receptor: modulation by pH and by PEGylation at the N terminus. Protein Sci 11, 1825, 2002.
33. Zhang, Z., Artelt, M., Burnet, M., Trautmann, K., and Schluesener, H.J. Early infiltration of CD8+ macrophages/ microglia to lesions of rat traumatic brain injury. Neuroscience 141, 637, 2006.
34. Streit, W.J. Microglia as neuroprotective, immunocompetent cells of the CNS. Glia 40, 133, 2002.
35. Holmin, S., Almqvist, P., Lendahl, U., and Mathiesen, T. Adult nestin-expressing subependymal cells differentiate to astrocytes in response to brain injury. Eur J Neurosci 9, 65, 1997.